Composite

Part:BBa_K2812007

Designed by: Guido Oerlemans, Maxime van den Oetelaar and Mariska Brls   Group: iGEM18_TU-Eindhoven   (2018-10-08)


Coding sequence for Pyocin S5 with HlyA and His6-tag regulated by pBAD-ara promoter

Coding sequence for Pyocin S5 fused to the secretion signal peptide HlyA via a thrombin linker. TU-Eindhoven 2018 designed this part to secrete pyocin S5 from Escherichia coli, under control of the pBAD-ara C promotor BBa_K2812002 inducible with arabinose, to kill P. aeruginosa biofilms for the treatment of wound infections. For more information about our project, please visit our wiki.

Usage and Biology

Pyocin S5

Pyocin S5 is a bacteriocin produced by a specific strain of Pseudomonas aeruginosa. Its lytic activity is initiated by binding of pyocin S5 to the outer membrane receptors of cells that are susceptible. Pyocin S5 consists out of three domains, a translocation, a receptor binding and a killing domain. Pyosin S5 induces membrane damage, resulting in the leakage of intracellular materials and subsequent cell death. It has been proven to have a bactericidal effect against seven P. aeruginosastrains that are clinically relevant.1

HlyA

The C-terminal sequence of Hemolysin A (residues 807-1024 of the E. coli HlyA gene) functions as a non-cleavable signal peptide for protein translocation via the Type I secretion pathway of Gram-negative bacteria. Here, HlyA is fused to the pyocin S5 for its secretion from E. coli BL21 (DE3) cells. In Type I secretion, single step transport of the target protein occurs from the cytoplasm to the extracellular environment. The HlyA is fused to the C-terminus of the target protein.2 It is a 23-kDa signal sequence that targets proteins for secretion via Type I secretion pathway. HlyA is secreted into the medium in a TolC and HlyB/D-dependent manner, in the presence of CaCl2.3 It is recognized by the membrane translocation complex composed of HlyB and HlyD, which together with the TolC protein, will form a pore through the membrane.4 This will lead to the secretion of HlyA-containing fusion proteins. Figure 1 illustrates the steps involved in the type I secretion of pyocin S5 as an HlyA fusion protein.

pBAD-ara promotor, Thrombin linker & His-tag

The pBAD-ara promoter is part of the arabinose operon. The biobrick is under the control of the pBAD-ara promoter BBa_K2812002 and can be induced by addition of arabinose. The pyocin S5 and HlyA are linked via a thrombin linker. It is a short peptide sequence which can be cleaved by the enzyme thrombin, resulting in the removal of the HlyA domain. This avoids interference with the functionality of pyocin S5. C-terminal to the HlyA domain, a His-tag (6x repeated amino acid histidine) is attached. The His-tag can be used for detection of the fusion protein by e.g. Western Blot, but also for protein purification purposes as it facilitates binding to a nickel affinity column.

Fusion protein

The combination of all components described above, lead to a construct that can be (continuously) secreted by E. coli if the HlyB/D coding sequences have been co-transformed. Running the medium containing the fusion protein over a nickel affinity column and subsequent thrombin linker cleavage allows for the easy isolation of purified pyocin S5.

Figure 1: Type I secretion of pyocin S5 via HlyA, HlyB, HlyD and TolC. IM = inner membrane; OM = outer membrane; A = HlyA; P = Pyocin S5

Experimental Characterisation by TU-Eindhoven (2018)

Figure 1: 1% agarose gel of the colony PCR of the Pyocin S5-HlyA biobrick.

Cloning

TU-Eindhoven 2018 has characterized the biobrick BBa_K2812006 at the DNA level. First, the pBAD-ara promoter-pyocin S5-thrombin linker-HlyA-His-tag construct was synthesized by IDT and subsequently double digested and assembled into the digested linearized pSB1C3 backbone via ligation. The ligated construct was successfully transformed into E. coli NovaBlue, followed by a colony PCR using the VF2 and VR primers to investigate if the correct length has been inserted in the vector. The mixture was ran on a 1% agarose gel as can be seen in figure 1. The observed length of the brightest band corresponds with the expected length of 2602 basepairs, confirming that the desired construct has been succesfully ligated in pSB1C3 and subsequently transformed in E. coli NovaBlue. Next, the colonies with the correct insert were cultured in LB before a plasmid purification by a miniprep. The isolated plasmid DNA was sent for Sanger sequencing and the sequence could be confirmed.

Sources

1) Ling, Hua, et al. A predicted S‐type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage. FEBS letters 584.15 (2010): 3354-3358.

2) Thomas, S., Holland, I. B., & Schmitt, L. (2014). The Type 1 secretion pathway — The hemolysin system and beyond. Molecular Cell Research, 1629-1641.

3) Gray, L., Baker, K., Kenny, B., Mackman, N., Haigh, R., & Holland, I. (1989). A novel C-terminal signal sequence targets Escherichia coli haemolysin directly to the medium. J Cell Sci Suppl., 45-57.

4) Wandersman, C., & Delepelaire, P. (1990 ). TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci U S A., 4776-4780.


Sequence and Features

Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 208
    Illegal BglII site found at 496
    Illegal BglII site found at 2181
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


[edit]
Categories
//cds
//cds/enzyme
//cds/enzyme/lysis
//cds/membrane
//cds/membrane/lysis
//chassis/prokaryote/ecoli
//collections/biofilm
//plasmid/expression
//plasmidbackbone/expression/inducible
//plasmidbackbone/proteinfusion
//plasmidbackbone/synthesis
//proteindomain
//proteindomain/cleavage
//proteindomain/degradation
//proteindomain/linker
//proteindomain/localization
Parameters
None